Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scimera BioScience is a healthcare company focused on developing and commercializing evidence-based nutraceuticals and dietary supplements. The company specializes in high-potency formulations designed to address specific health concerns such as digestive wellness, immune support, and joint health. Their flagship products, including the Asprega probiotic line, are developed through collaboration with physicians and pharmacists to ensure clinical relevance and efficacy. Scimera operates primarily in the consumer health space, bridging the gap between traditional medicine and nutritional supplementation. The company emphasizes quality control and utilizes advanced delivery technologies to enhance the bioavailability of its formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scimera BioScience.